NCT06851156 Transcranial Temporal Interference Stimulation In Severely Brain Injured Patients With Disorders of Consciousness
| NCT ID | NCT06851156 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xijing Hospital |
| Condition | Disorders of Consciousness |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2025-04-07 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2025-04-07 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this academic lead study is to explore the effect of noninvasive neuromodulation of the CM-pf via tTIS for patients with disorders of consciousness.
Eligibility Criteria
Inclusion Criteria: * traumatic and nontraumatic etiology of VS/UWS or MCS according to published diagnostic criteria. Exclusion Criteria: * patients in coma, with less than 1 week after acute brain insult, with fluctuating diagnosis on baseline assessment, and with a metallic cerebral implant or pacemaker, and with epilepsy.
Contact & Investigator
wen Jiang, phD
PRINCIPAL INVESTIGATOR
Xijing Hospital
Frequently Asked Questions
Who can join the NCT06851156 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Disorders of Consciousness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06851156 currently recruiting?
Yes, NCT06851156 is actively recruiting participants. Contact the research team at 304517021@qq.com for enrollment information.
Where is the NCT06851156 trial being conducted?
This trial is being conducted at Xi'an, China, Xi'an, China.
Who is sponsoring the NCT06851156 clinical trial?
NCT06851156 is sponsored by Xijing Hospital. The principal investigator is wen Jiang, phD at Xijing Hospital. The trial plans to enroll 10 participants.